BRIEF published on 06/30/2025 at 14:35, 9 months 21 days ago Greenlane nomme Mike Hinson au poste de vice-président exécutif des ventes Optimisation Des Revenus Produits À Base De Cannabis Stratégie De Vente Voie Verte Mike Hinson
BRIEF published on 06/30/2025 at 14:35, 9 months 21 days ago Amaze Holdings Partners with VisitIQ for Enhanced Audience Insights Creator Economy Amaze Holdings VisitIQ Integration Audience Insights AI Segmentation
BRIEF published on 06/30/2025 at 14:35, 9 months 21 days ago Amaze Holdings s'associe à VisitIQ pour une meilleure compréhension de son audience Économie Des Créateurs Amaze Holdings Intégration VisitIQ Informations Sur L'audience Segmentation De L'IA
BRIEF published on 06/30/2025 at 14:29, 9 months 21 days ago Jaguar Health: FDA Dialogue and Strategic Trials Crofelemer Clinical Trials Jaguar Health Breast Cancer FDA Meeting
BRIEF published on 06/30/2025 at 14:29, 9 months 21 days ago Jaguar Health : Dialogue avec la FDA et essais stratégiques Crofelemer Jaguar Health Essais Cliniques Cancer Du Sein Réunion De La FDA
BRIEF published on 06/30/2025 at 14:10, 9 months 21 days ago Kingstone Companies Joins Russell 3000 and Russell 2000 Indexes Market Capitalization Institutional Investment Kingstone Companies Russell Indexes Insurance Holding
BRIEF published on 06/30/2025 at 14:10, 9 months 21 days ago Kingstone Companies rejoint les indices Russell 3000 et Russell 2000 Capitalisation Boursière Investissement Institutionnel Kingstone Companies Indices Russell Holding D'assurance
BRIEF published on 06/30/2025 at 14:05, 9 months 21 days ago Promising Phase 1b Results for invIOs's APN401 Cell Therapy in Advanced Tumors Cell Therapy Phase 1b Trial InvIOs GmbH APN401 Advanced Tumors
BRIEF published on 06/30/2025 at 14:05, 9 months 21 days ago Résultats prometteurs de phase 1b pour la thérapie cellulaire APN401 d'invIOs dans les tumeurs avancées Thérapie Cellulaire InvIOs GmbH APN401 Essai De Phase 1b Tumeurs Avancées
BRIEF published on 06/30/2025 at 14:05, 9 months 21 days ago MIRA Unveils Promising Results for SKNY-1 in Zebrafish Study Weight Loss Obesity Treatment MIRA Pharmaceuticals SKNY-1 Nicotine Cravings
Published on 04/22/2026 at 01:55, 3 hours 57 minutes ago Immutable Holdings Announces Director Resignation
Published on 04/22/2026 at 01:30, 4 hours 22 minutes ago Challenger West Assays Return Grades up to 60g/t Au
Published on 04/22/2026 at 00:00, 5 hours 52 minutes ago Zimtu Capital Corp. and Global Energy Metals Corporation Agree to Terminate Option Agreement for the Monument Peak Copper-Silver Project, Idaho
Published on 04/22/2026 at 00:00, 5 hours 52 minutes ago Grande Portage Resources Announces SEDAR+ Filing of Preliminary Economic Assessment (PEA) Study for the New Amalga Gold Project in SE Alaska
Published on 04/21/2026 at 22:15, 7 hours 37 minutes ago Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting
Published on 04/21/2026 at 20:50, 9 hours 2 minutes ago CATL Unveils Six Major Innovations: Multi-Chemistry Systems to Redefine New Energy Mobility Experience
Published on 04/21/2026 at 19:15, 10 hours 37 minutes ago Shelly Group SE publishes 2025 Investors Report as an established transparency format
Published on 04/21/2026 at 19:08, 10 hours 43 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/21/2026 at 19:02, 10 hours 49 minutes ago Brockhaus Technologies AG: Actions for annulment and nullity against the approval resolution of the Extraordinary General Meeting of February 26, 2026
Published on 04/21/2026 at 19:15, 10 hours 37 minutes ago AXA - Description of the Company’s share repurchase program
Published on 04/21/2026 at 19:15, 10 hours 37 minutes ago AXA - Descriptif du programme de rachat d’actions
Published on 04/21/2026 at 18:00, 11 hours 52 minutes ago Outstanding shares and voting rights statement at 31 March 2026
Published on 04/21/2026 at 18:00, 11 hours 52 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mars 2026
